BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37362207)

  • 1. Construction of an alpaca immune antibody library for the selection of nanobodies against
    Qiu J; Li J; Zhang Z; Dong S; Ling X; Fang Z; Ling Q; Huang Z
    Front Bioeng Biotechnol; 2023; 11():1207048. PubMed ID: 37362207
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and production of nanobodies specifically against green fluorescence protein.
    Fang Z; Cao D; Qiu J
    Appl Microbiol Biotechnol; 2020 Jun; 104(11):4837-4848. PubMed ID: 32270250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Screening and activity analysis of nanobodies against lymphocyte activation gene-3(LAG-3)].
    Wen R; Chen Y; Yang Z; Yan F; Li Q; Wu W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Number; 39(11):1024-1031. PubMed ID: 37980554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of a novel nanobody with SRMV neutralizing activity.
    Sun M; Wang C; Luo H; Chen Y; Qu G; Chen J; Li L; Zhang M; Xue Q
    Microb Cell Fact; 2024 Feb; 23(1):45. PubMed ID: 38341572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An alpaca single-domain antibody (VHH) phage display library constructed by CDR shuffling provided high-affinity VHHs against desired protein antigens.
    Tsukahara N; Murakami A; Motohashi M; Nakayama H; Kondo Y; Ito Y; Azuma T; Kishimoto H
    Int Immunol; 2022 Jul; 34(8):421-434. PubMed ID: 35689594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microcystin-LR nanobody screening from an alpaca phage display nanobody library and its expression and application.
    Xu C; Yang Y; Liu L; Li J; Liu X; Zhang X; Liu Y; Zhang C; Liu X
    Ecotoxicol Environ Saf; 2018 Apr; 151():220-227. PubMed ID: 29353171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a Nanobodies Phage Display Library From an Escherichia coli Immunized Dromedary.
    Salhi I; Bessalah S; Snoun D; Khorchani T; Hammadi M
    Iran J Biotechnol; 2020 Jan; 18(1):e2247. PubMed ID: 32884952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high affinity nanobody against endothelin receptor type B: a new approach to the treatment of melanoma.
    Ji L; Dong C; Fan R; Qi S
    Mol Biol Rep; 2020 Mar; 47(3):2137-2147. PubMed ID: 32080807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining of synthetic VHH and immune scFv libraries for pregnancy-associated glycoproteins ELISA development.
    Dormeshkin D; Shapira M; Karputs A; Kavaleuski A; Kuzminski I; Stepanova E; Gilep A
    Appl Microbiol Biotechnol; 2022 Aug; 106(13-16):5093-5103. PubMed ID: 35723693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of naïve camelids VHH repertoire in phage display-based library.
    Sabir JS; Atef A; El-Domyati FM; Edris S; Hajrah N; Alzohairy AM; Bahieldin A
    C R Biol; 2014 Apr; 337(4):244-9. PubMed ID: 24702893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of nanobodies targeting GPCR.
    Zhang S; Fan Z; Liu J
    Biophys Rep; 2024 Feb; 10(1):22-30. PubMed ID: 38737476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing and characterizing a single-domain antibody (nanobody) against human cytotoxic T-lymphocyte-associated protein 4 (hCTLA-4).
    Sotoudeh N; Noormohammadi Z; Habibi-Anbouhi M; Kazemi-Lomedasht F; Behdani M
    Iran J Basic Med Sci; 2021 Sep; 24(9):1264-1271. PubMed ID: 35083014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and Characterization of Single-Domain Antibodies from Immune Phage Display Libraries.
    Rossotti MA; Trempe F; van Faassen H; Hussack G; Arbabi-Ghahroudi M
    Methods Mol Biol; 2023; 2702():107-147. PubMed ID: 37679618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation and identification of anti-follicle-stimulating hormone receptor nanobodies].
    Xia X; M M; Zhai T; Li J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):829-33. PubMed ID: 23948408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Two-Step Approach for the Design and Generation of Nanobodies.
    Wagner HJ; Wehrle S; Weiss E; Cavallari M; Weber W
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of novel CD19-specific VHHs isolated from a camelid immune library by phage display.
    Ganji M; Safarzadeh Kozani P; Rahbarizadeh F
    J Transl Med; 2023 Dec; 21(1):891. PubMed ID: 38066569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Colorectal Cancer Cell Lines Using Nanobodies; AgSK1as a Potential Target.
    Rashidi SK; Mousavi Gargari SL; Ebrahimizadeh W
    Iran J Biotechnol; 2017; 15(2):78-86. PubMed ID: 29845054
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening, Expression and Identification of Nanobody Against Monkeypox Virus A35R.
    Meng N; Cheng X; Sun M; Zhang Y; Sun X; Liu X; Chen J
    Int J Nanomedicine; 2023; 18():7173-7181. PubMed ID: 38076734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploiting Nanobodies in the Detection and Quantification of Human Growth Hormone
    Murad H; Assaad JM; Al-Shemali R; Abbady AQ
    Front Endocrinol (Lausanne); 2017; 8():115. PubMed ID: 28611730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii.
    Payandeh Z; Rasooli I; Mousavi Gargari SL; Rajabi Bazl M; Ebrahimizadeh W
    Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):92-8. PubMed ID: 24463583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.